首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
【24h】

Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.

机译:Ouabainlike Na +,K + -Atpase抑制剂在正常肌肤和高血压的人和大鼠等血浆中。

获取原文
           

摘要

Acute volume expansion, increased sodium intake, and restraint on sodium excretion endow the plasma with an increased capacity to inhibit sodium transport. Cytochemical techniques can detect the presence of Na+K+-adenosine triphosphatase (ATPase) inhibitor in the plasma of normal humans and rats, the concentration of which is controlled by salt intake. The substance responsible appears to originate in the hypothalamus, where the concentration is also controlled by salt intake. The plasma concentration of the cytochemically detectable Na+,K+-ATPase inhibitor is substantially raised in the plasma of patients with essential hypertension, spontaneously hypertensive rats (SHR) and of Milan hypertensive rats. The concentration of activity in the hypothalamus of SHR is also considerably raised. These findings demonstrate that these forms of hypertension are associated with a rise in the concentration of a cytochemically detectable circulating Na+,K+-ATPase inhibitor that under normal circumstances is controlled by salt intake.
机译:急性体积膨胀,增加的钠摄入量,并抑制钠排泄的抑制额增加了抑制钠运输的能力增加。细胞化学技术可以检测正常人和大鼠血浆中Na + k + -denoosine三磷酸酶(ATP酶)抑制剂的存在,其浓度由盐摄入量控制。负责的物质似乎源自下丘脑,其中浓度也通过盐摄入来控制。细胞化学检测的Na +,K + -ATPase抑制剂的血浆浓度在患有精神上的高血压患者,自发性高血压大鼠(SHR)和米兰高血压大鼠的患者的血浆中显着升高。 SHR下丘脑中的活性浓度也大大提高。这些发现表明,这些形式的高血压与细胞化学检测的循环Na +,K + -ATPase抑制剂的浓度的上升相关,即在正常情况下由盐摄入控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号